Skip to main content
Top
Published in: Journal of Artificial Organs 4/2016

01-12-2016 | Case Report

Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton–Valentine leukocidin—positive Staphylococcus aureus pneumonia and H1N1

Authors: NJ Lees, AJP Rosenberg, AI Hurtado-Doce, J Jones, N Marczin, M Zeriouh, A Weymann, A Sabashnikov, AR Simon, AF Popov

Published in: Journal of Artificial Organs | Issue 4/2016

Login to get access

Abstract

Sepsis-induced cardiogenic shock in combination with severe acute respiratory failure represents a life-threatening combination that is often refractory to the conventional methods of treatment. We describe the case of a 33-year-old patient who developed acute cardiovascular collapse and ARDS secondary to superinfection of Panton–Valentine leukocidin—positive Staphylococcus aureus and H1N1 pneumonia who underwent successful combination therapy for severe sepsis-related cardiomyopathy and respiratory failure using extracorporeal membrane oxygenation and cytokine adsorption therapy.
Literature
1.
go back to reference Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton–Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753–9.CrossRefPubMed Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton–Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753–9.CrossRefPubMed
2.
go back to reference Gauduchon V, Cozon G, Vandenesch F, et al. Neutralization of Staphylococcus aureus Panton–Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis. 2004;189:346–53.CrossRefPubMed Gauduchon V, Cozon G, Vandenesch F, et al. Neutralization of Staphylococcus aureus Panton–Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis. 2004;189:346–53.CrossRefPubMed
3.
go back to reference Rouzic N, Janvier F, Libert N, et al. Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton–Valentine leukocidin genes. J Clin Microbiol. 2010;48:1952–5.CrossRefPubMedPubMedCentral Rouzic N, Janvier F, Libert N, et al. Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton–Valentine leukocidin genes. J Clin Microbiol. 2010;48:1952–5.CrossRefPubMedPubMedCentral
4.
go back to reference Morgan MS. Diagnosis and treatment of Panton–Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int J Antimicrob Agents. 2007;30:289–96.CrossRefPubMed Morgan MS. Diagnosis and treatment of Panton–Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int J Antimicrob Agents. 2007;30:289–96.CrossRefPubMed
5.
go back to reference Salliot C, Zeller V, Puechal X, et al. Panton–Valentine leukocidin-producing Staphylococcus aureus infections: report of 4 French cases. Scand J Infect Dis. 2006;38:192–5.CrossRefPubMed Salliot C, Zeller V, Puechal X, et al. Panton–Valentine leukocidin-producing Staphylococcus aureus infections: report of 4 French cases. Scand J Infect Dis. 2006;38:192–5.CrossRefPubMed
6.
go back to reference Noah MA, Dawrant M, Faulkner GM, et al. Panton–Valentine leukocidin expressing Staphylococcus aureus pneumonia managed with extracorporeal membrane oxygenation: experience and outcome. Crit Care Med. 2010;38:2250–3.CrossRefPubMed Noah MA, Dawrant M, Faulkner GM, et al. Panton–Valentine leukocidin expressing Staphylococcus aureus pneumonia managed with extracorporeal membrane oxygenation: experience and outcome. Crit Care Med. 2010;38:2250–3.CrossRefPubMed
7.
go back to reference Fujisaki N, Takahashi A, Arima T, et al. Successful treatment of Panton–Valentine leukocidin-expressing Staphylococcus aureus-associated pneumonia co-infected with influenza using extracorporeal membrane oxygenation. In Vivo. 2014;28:961–5.PubMed Fujisaki N, Takahashi A, Arima T, et al. Successful treatment of Panton–Valentine leukocidin-expressing Staphylococcus aureus-associated pneumonia co-infected with influenza using extracorporeal membrane oxygenation. In Vivo. 2014;28:961–5.PubMed
8.
go back to reference Maclaren G, Butt W. Extracorporeal membrane oxygenation and sepsis. Critical care and resuscitation J Australas Acad Cri Care Med. 2007;9:76–80. Maclaren G, Butt W. Extracorporeal membrane oxygenation and sepsis. Critical care and resuscitation J Australas Acad Cri Care Med. 2007;9:76–80.
9.
go back to reference Brechot N, Luyt CE, Schmidt M, et al. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med. 2013;41:1616–26.CrossRefPubMed Brechot N, Luyt CE, Schmidt M, et al. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med. 2013;41:1616–26.CrossRefPubMed
10.
go back to reference Gabel E, Gudzenko V, Cruz D, et al. Successful use of extracorporeal membrane oxygenation in an adult patient with toxic shock-induced heart failure. J Intensive Care Med. 2015;30:115–8.CrossRefPubMed Gabel E, Gudzenko V, Cruz D, et al. Successful use of extracorporeal membrane oxygenation in an adult patient with toxic shock-induced heart failure. J Intensive Care Med. 2015;30:115–8.CrossRefPubMed
11.
go back to reference Nakada TA, Oda S, Matsuda K, et al. Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock. Mol Med. 2008;14:257–63.CrossRefPubMedPubMedCentral Nakada TA, Oda S, Matsuda K, et al. Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock. Mol Med. 2008;14:257–63.CrossRefPubMedPubMedCentral
12.
go back to reference Song M, Winchester J, Albright RL, et al. Cytokine removal with a novel adsorbent polymer. Blood Purif. 2004;22:428–34.CrossRefPubMed Song M, Winchester J, Albright RL, et al. Cytokine removal with a novel adsorbent polymer. Blood Purif. 2004;22:428–34.CrossRefPubMed
13.
go back to reference Morris C, Gray L, Giovannelli M. Early report: the use of Cytosorb haemoabsorption column as an adjunct in managing severe sepsis: initial experiences, review and recommendations. J Intensive Care Soc. 2015;16:257–64.CrossRef Morris C, Gray L, Giovannelli M. Early report: the use of Cytosorb haemoabsorption column as an adjunct in managing severe sepsis: initial experiences, review and recommendations. J Intensive Care Soc. 2015;16:257–64.CrossRef
14.
go back to reference Hetz H, Berger R, Recknagel P, et al. Septic shock secondary to beta-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs. 2014;37:422–6.CrossRefPubMed Hetz H, Berger R, Recknagel P, et al. Septic shock secondary to beta-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs. 2014;37:422–6.CrossRefPubMed
15.
go back to reference Basu R, Pathak S, Goyal J, et al. Use of a novel hemadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: a case study. Indian J Crit Care Med. 2014;18:822–4.CrossRefPubMedPubMedCentral Basu R, Pathak S, Goyal J, et al. Use of a novel hemadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: a case study. Indian J Crit Care Med. 2014;18:822–4.CrossRefPubMedPubMedCentral
16.
go back to reference Bruenger F, Kizner L, Weile J, et al. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report. Int J Artif Organs. 2015;38:113–6.CrossRefPubMed Bruenger F, Kizner L, Weile J, et al. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report. Int J Artif Organs. 2015;38:113–6.CrossRefPubMed
17.
go back to reference Bracht H, Schneider EM, Weiss M, Hohmann H, Georgieff M, Barth E. Pattern of cytokine removal using an adsorption column CytoSorb during severe Candida albicans induced septic shock. Infection. 2013;41:S1–90. Bracht H, Schneider EM, Weiss M, Hohmann H, Georgieff M, Barth E. Pattern of cytokine removal using an adsorption column CytoSorb during severe Candida albicans induced septic shock. Infection. 2013;41:S1–90.
Metadata
Title
Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton–Valentine leukocidin—positive Staphylococcus aureus pneumonia and H1N1
Authors
NJ Lees
AJP Rosenberg
AI Hurtado-Doce
J Jones
N Marczin
M Zeriouh
A Weymann
A Sabashnikov
AR Simon
AF Popov
Publication date
01-12-2016
Publisher
Springer Japan
Published in
Journal of Artificial Organs / Issue 4/2016
Print ISSN: 1434-7229
Electronic ISSN: 1619-0904
DOI
https://doi.org/10.1007/s10047-016-0915-8

Other articles of this Issue 4/2016

Journal of Artificial Organs 4/2016 Go to the issue